Hologic

Hologic Competitive Intelligence & Landscape

hologic.com ·

Overview

Hologic Overview

Hologic (hologic.com) is a global medical technology company dedicated to improving women's health through innovative solutions in diagnostics, medical imaging, and surgical health. Founded in 1985, the company's mission is to help women around the world live healthier lives by developing technologies that effectively detect, diagnose, and treat health conditions, thereby raising the standard of care globally [https://hologic.com/about].

Hologic specializes in several key areas. Its Women's Health products include solutions for Breast Health, Gynecological Health, Sexual Health, Body Composition, and Skeletal Health. In Lab Technologies, Hologic offers Tests, Cytology, Molecular Diagnostics, Oncology, Collection Devices, and Screening Technologies. The company supports healthcare professionals with comprehensive educational resources, patient materials, and robust customer support services including sales representatives and technical assistance [https://hologic.com/].

Hologic is headquartered in Marlborough, Massachusetts, and operates in over 36 countries, demonstrating a significant global presence. The company employs approximately 7,000 individuals worldwide and holds more than 4,100 patents. With a focus on purpose, passion, and promise, Hologic emphasizes that women's health is more than a business; it is their core purpose, recognizing women as cornerstones of society and believing that improving their health creates a powerful ripple effect on families and communities [https://www.hologic.com/support/locations, https://www.hologic.com/sustainability].

Hologic

Hologic Weekly Intel Updates

Receive weekly intel updates about Hologic straight to your inbox.

Competitors

Hologic Competitors

Hologic (hologic.com) faces competition from various medical technology and diagnostics companies. One significant competitor is BD (Becton, Dickinson and Company), which offers a broad portfolio of medical devices, laboratory equipment, and diagnostic products. While Hologic specializes in women's health, diagnostics, and medical imaging, BD has a more diversified market presence across various healthcare segments, including medication management, infection prevention, and surgical solutions. The companies compete in areas like diagnostic testing and medical technology for disease detection.

Medix Biochemica is another competitor, primarily focused on diagnostic raw materials and reagents. Unlike Hologic, which provides integrated medical technologies and diagnostic platforms directly to healthcare providers, Medix Biochemica operates further up the supply chain, offering critical components to other diagnostic test manufacturers. This makes them an indirect competitor, as their offerings enable other companies to create products that may compete with Hologic's diagnostic tests.

Qiagen is a key player in sample and assay technologies for molecular diagnostics, applied testing, and academic research. Similar to Hologic's molecular diagnostics offerings, Qiagen provides solutions for disease detection and research.

Qiagen's focus on molecular biology and genomics differentiates it, while Hologic maintains a strong emphasis on women's health, including breast health, gynecological health, and sexual health.

Roche Diagnostics Automation Solutions, mentioned as a competitor, specializes in personalized medicine and diagnostics. This company develops personalized medications, diagnostic tests, and digital technologies. While Hologic also offers diagnostic tests, Roche Diagnostics Automation Solutions has a broader scope in personalized medicine, potentially offering different features and targeting a wider range of diagnostic needs beyond Hologic's core women's health focus. This makes them a direct competitor in the broader diagnostics market, particularly with their advanced diagnostic technologies.

Finally, Boston Scientific is identified as a significant competitor.

Boston Scientific develops, manufactures, and markets medical devices used in interventional cardiology, peripheral interventions, and neuromodulation, among other areas. While Hologic focuses on diagnostic and surgical products primarily for women's health, Boston Scientific offers a wider range of medical devices and procedures across multiple specialties. This creates competitive overlap in certain medical device markets, although Hologic's specialized focus on women's health gives it a unique market positioning.

Product & Pricing

Hologic Product and Pricing Intelligence

Hologic provides a range of medical technologies and diagnostic solutions, often requiring direct consultation for specific product and service pricing. Their offerings include sophisticated systems like the Selenia Dimensions Mammography System, designed for digital mammography with tomosynthesis capability, and the advanced Genius Digital Diagnostics System, the first and only FDA-cleared digital cytology system combining AI with volumetric imaging to detect pre-cancerous lesions and cervical cancer cells [https://www.hologic.com/hologic-products/breast-health-solutions/selenia-dimensions-mammography-system][https://www.hologic.com/en/hologic-products/cytology/genius-digital-diagnostics-system]. They also offer the Envision Mammography Platform, a next-generation 3D mammography solution featuring fast 3D scan times and enhanced by Hologic AI technologies for breast cancer detection [https://www.hologic.com/hologic-products/breast-health-solutions/envision-mammography-platform].

For ongoing support and optimization of their systems, Hologic offers SureCare Service plans, which are customizable to meet specific system and budgetary needs. These plans range from entry-level options with telephone and remote support to comprehensive packages that include productivity solutions, ensuring customers can maximize their investment in Hologic products [https://www.hologic.com/surgical-solutions]. While specific pricing for these plans is not publicly disclosed, their tiered structure indicates varying levels of support and features.

In terms of pricing initiatives, Hologic, in collaboration with MedAccess, Unitaid, and the Clinton Health Access Initiative, Inc. (CHAI), announced a significant pricing agreement in 2018. This agreement aimed to substantially reduce the cost of diagnostic testing for HIV/AIDS, hepatitis, and cervical cancer for over 180 million individuals in low- and middle-income countries. This breakthrough pricing for the Hologic Panther® System was subject to certain minimum volume requirements for public-sector entities [https://www.hologic.com/sites/default/files/GAI%20FAQs.pdf]. The Panther Scalable Solutions further provide an economical and flexible platform for expanding testing menus with various Aptima® and Panther Fusion® Assays, with options to add modules like Panther Fusion® Module, Panther® Plus, Panther® Link, and Panther® Trax [https://www.hologic.com/hologic-products/diagnostic-solutions/panther-scalable-solutions].

Ad Campaigns

Hologic Ad Campaigns

See the live ads Hologic is running across Google, Meta, and LinkedIn — the creative, messaging, and platforms behind every campaign, updated automatically by ForesightIQ.

See of Hologic's ads

View ads

Hiring & Layoffs

Hologic Hiring and Layoffs

Hologic (hologic.com) is actively recruiting, with a strong emphasis on talent acquisition across various specialized fields to drive its mission in women's health. The company maintains dedicated career portals careers.hologic.com and na.careers.hologic.com to attract and engage potential employees, encouraging individuals to join their "talent community" for new job opportunity alerts. This proactive approach signals a continuous investment in human capital rather than recent layoffs.

Recent job postings showcase Hologic's strategic focus on innovation and market leadership, particularly within its Breast & Skeletal Health division. Notable openings include Product Security Engineer roles in Newark, DE; Marlborough, MA; and Santa Clara, CA, indicating a commitment to "Secure by Design" in their healthcare solutions [https://careers.hologic.com/en/search/300000393013699/product-security-engineer]. Additionally, the company is seeking Lead Software Engineers, Full Stack in Newark, DE, and Marlborough, MA, to develop innovative products in mammography and other areas [https://na.careers.hologic.com/en/search/300000429214837/lead-software-engineer-full-stack]. These roles suggest a significant push in research and development and the enhancement of existing technologies.

Beyond engineering and security, Hologic is also hiring for critical roles such as Medical Physicist in Newark, DE, and Marlborough, MA, to support diagnostic and therapeutic systems [https://careers.hologic.com/en/search/300000393528939/medical-physicist], and Senior Manager, Supply and Demand Planning across multiple locations including San Diego, CA, Boston, MA, and Newark, DE [https://careers.hologic.com/en/search/300000377277949/senior-manager-supply-and-demand-planning]. Other vacancies include Clinical Sales Specialist, Sr Manager, Pricing, Contracting, & Deal Desk Solutions, Lead Compliance Engineer, R&D, and Diagnostic Sales Specialist [https://careers.hologic.com/en/search, https://careers.hologic.com/search?page=2]. These diverse openings highlight Hologic's commitment to strengthening its global operations, from product development and security to supply chain management and sales, reinforcing its position as a leading innovator in women's health.

Leadership

Hologic Management and Leadership Team

Hologic (hologic.com) is led by a dedicated management team focused on women's health. Stephen P. MacMillan previously served as the Chairman, President, and Chief Executive Officer [hologic.com/sites/default/files/2024_Hologic_Executive_Summary.pdf]. He announced his retirement upon the close of the company's go-private transaction with Blackstone and TPG [hologic.com/about/press-release/hologic-chief-executive-officer-steve-macmillan-retire-upon-close-go-private]. In connection with this transaction, José (Joe) E. Almeida was appointed as the new Chief Executive Officer [hologic.com/about/press-release/blackstone-and-tpg-complete-acquisition-hologic].

The company's governance structure, including its Board of Directors, plays a crucial role in overseeing sustainability and facilitating accountability and transparency [hologic.com/sites/default/files/FY%202024%20Sustainability%20Report%20Stand%20Alone%20Appendix%20%28Data%20Summary%2C%20GRI%2C%20SASB%2C%20TCFD%2C%20Assurance%29.pdf]. Further details on Hologic's governance documents are available on their website [hologic.com/governance].

Hologic prides itself on developing talent from within, with 40% of its Global Leadership Team comprising individuals who have grown into leadership roles through internal development and experience [na.careers.hologic.com/en/science-of-selection]. The company's leadership is committed to its purpose of enabling healthier lives everywhere, every day, with a passion for championing women's health globally [hologic.com/message-our-chairman-president-and-ceo].

Financials

Hologic Financial Performance, Fundraising, M&A

Hologic (hologic.com) consistently demonstrates strong financial performance, reporting substantial revenues across its fiscal quarters. In the fourth quarter of fiscal 2025, the company achieved revenue of $1,049.5 million, marking a 6.2% increase, with GAAP diluted EPS of $0.83, up 9.2% Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025. The first quarter of fiscal 2026 saw revenues of $1,047.8 million, growing by 2.5% Hologic Announces Financial Results for First Quarter of Fiscal 2026. Earlier in fiscal 2025, Hologic reported $1,023.8 million in revenue for the third quarter and $1,021.8 million for the first quarter, with a slight dip to $1,005.3 million in the second quarter, yet consistently exceeding or meeting guidance Hologic Announces Financial Results for Third Quarter of Fiscal 2025, Hologic Announces Financial Results for First Quarter of Fiscal 2025, Hologic Announces Financial Results for Second Quarter of Fiscal 2025. The company's investor relations page provides comprehensive financial reports and a summary table for detailed financial insights Investor Relations | Hologic.

In a significant development, Hologic announced a definitive agreement to be acquired by funds managed by Blackstone and TPG. This transaction is valued at up to $79 per share, representing an enterprise value of up to $18.3 billion Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Revenue Milestones. The agreement details the merger with Parent Inc. and Hopper Merger Sub Inc., affiliates of Blackstone and TPG Capital Agreement and Plan of Merger. This acquisition highlights the company's attractive market position and strong financial standing within the women's health, diagnostics, and medical imaging sectors.

Hologic remains focused on its core purpose of advancing women's health, which is also emphasized in its annual sustainability report. This report details the company's progress across key environmental, social, and governance priorities, reflecting a commitment to long-term value creation beyond just financial metrics Hologic | Women's Health, Diagnostics & Medical Imaging.

Partnerships

Hologic Partnerships, Clients and Vendors

Hologic engages in strategic partnerships and collaborations to advance its medical technologies and expand its global reach. Notably, Hologic has partnered with Google Cloud to integrate machine learning and artificial intelligence into its next-generation digital diagnostic capabilities, including the Genius Digital Diagnostics System, aiming to improve laboratory performance and patient care [https://www.hologic.com/about/hologic-highlights/hologic-and-google-cloud-announce-collaboration-advance-next-generation][https://www.hologic.com/en/hologic-products/cytology/genius-digital-diagnostics-system].

Hologic also collaborates with other organizations on specific health initiatives. An agreement with the Centers for Disease Control and Prevention (CDC) focuses on developing analyte specific reagents to aid in the detection of H5N1 bird flu [https://www.hologic.com/about/press-release/hologic-contribute-h5n1-bird-flu-test-development-agreement-issued-cdc]. Furthermore, Hologic and Grifols co-developed the Procleix Zika Virus Assay, which was approved by the FDA for screening the U.S. blood supply [https://investors.hologic.com/press-releases/press-release-details/2016/FDA-Approves-Use-of-the-Procleix-Zika-Virus-Assay-from-Hologic-and-Grifols-to-Screen-the-U-S--Blood-Supply-Under-an-IND-Study-Protocol/default.aspx].

To address global health challenges, Hologic leads the Global Access Initiative in partnership with the Clinton Health Access Initiative, Inc. (CHAI) and MedAccess. This initiative provides accessible and affordable testing using the Panther® system in high-prevalence viral disease areas [https://www.hologic.com/globalaccessinitiative].

Hologic also contributes to the NEST Governance Committee, leveraging its expertise in women's health to help shape the future of healthcare innovation through real-world evidence generation [https://www.hologic.com/about/newsroom/how-real-world-evidence-shaping-future-healthcare-innovation].

Hologic's products and systems are designed for integration within existing healthcare infrastructures. Their Application Synchronization software for the SecurView® diagnostic workstation supports common login and patient synchronization with over 60 RIS, reporting, and dictation systems, including Epic Radiant RIS [https://www.hologic.com/sites/default/files/SS-00153_Rev003-SecurView_AppSync_v6.pdf]. Additionally, Hologic provides interfaces for partners to integrate with its systems, such as the Command Line Proxy, SharedFile, and TCP/IP interfaces, with examples including integration with Siemens syngo Workflow (Europe) [https://www.hologic.com/file/405846/download?token=Eln3lEVx][https://www.hologic.com/file/404701/download?token=A2ZEOPKN].

Events

Hologic Event Participations

Hologic actively participates in a variety of events, from major medical conferences to educational webinars, to showcase its innovations and support healthcare professionals. The company regularly attends significant industry gatherings such as the CAP (College of American Pathologists) 2026, DPA (Digital Pathology Association) 2026, AMP (Association for Molecular Pathology) 2026, and SABCS [hologic.com/events].

Hologic also has a strong presence at events focused on women's health and medical imaging. For instance, the company will be at RSNA (Radiological Society of North America) 2026 in Chicago to present its advancements in breast and skeletal health, covering everything from screening to surgery [hologic.com/rsna]. New data on Hologic's AI-powered mammography solutions are frequently presented at these types of events, including the RSNA Scientific Assembly and Annual Meeting [hologic.com/about/press-release/new-clinical-evidence-hologics-ai-powered-mammography-solutions-will-be] and the European Society of Breast Imaging (EUSOBI) [hologic.com/about/press-release/new-data-hologics-ai-powered-mammography-technology-be-presented-eusobi]. Furthermore, Hologic will be showcasing new breast surgery innovations, including the launch of their MagSeed Pro® magnetic marker and the full line of newly acquired Endomag products, at the 2025 American Society of Breast Surgery (ASBrS) Annual Meeting in Las Vegas [hologic.com/asbrs].

In addition to these conferences, Hologic is committed to ongoing education through webinars. They offer educational webinars focused on cervical health, allowing healthcare professionals to stay updated on the latest advancements and technologies in screening and diagnostics [hologic.com/thinpreptechnician, hologic.com/thinpreplaboratory]. These webinars, along with free in-person and virtual training, are part of Hologic's broader commitment to cytology professional awareness and development [hologic.com/totalcervicalhealth]. The company also hosts webinars with leading experts on topics like respiratory health, sharing experiences in an evolving field [hologic.com/readyandresilient].

Beyond medical and educational events, Hologic engages with the investment community. The company provides webcast presentations at investor conferences, such as Wells Fargo’s Healthcare Conference and Morgan Stanley’s Annual Global Healthcare Conference, to discuss its financial performance and strategic outlook [hologic.com/about/press-release/hologic-webcast-presentations-upcoming-investor-conferences].

Frequently Asked Questions

What is Hologic's current strategic focus based on its recent hiring activities?

Hologic is strategically focused on enhancing its innovation and market leadership, particularly within its Breast & Skeletal Health division. Recent job postings for Product Security Engineer, Lead Software Engineer (Full Stack), and Medical Physicist roles indicate a strong commitment to R&D, secure product design, and the development of advanced mammography and diagnostic systems.

How does Hologic's event participation signal its strategic priorities?

Hologic's active participation in major medical conferences like RSNA 2026, ASBrS 2025, and EUSOBI, alongside its educational webinars, signals a strategic priority on showcasing advancements in breast and skeletal health, medical imaging (especially AI-powered mammography), and cervical health diagnostics. These events are used to launch new products, present clinical data, and provide professional development.

What does Hologic's financial performance indicate about its market position ahead of its acquisition?

Hologic consistently demonstrates strong financial performance, with revenues over $1 billion in recent fiscal quarters, including a 6.2% increase in Q4 FY2025. This robust performance, combined with a valuation of up to $18.3 billion in its acquisition by Blackstone and TPG, highlights Hologic's attractive and strong market position within women's health, diagnostics, and medical imaging.

What is the implication of Hologic's go-private transaction for its leadership structure?

Hologic's go-private transaction with Blackstone and TPG has led to a significant leadership change. Stephen P. MacMillan retired as Chairman, President, and CEO upon the close of the transaction, and José (Joe) E. Almeida was appointed as the new Chief Executive Officer, signaling a new era of leadership under private equity ownership.

How does Hologic's competitive landscape inform its strategic differentiation?

Hologic operates in a competitive landscape with diverse players such as BD, Qiagen, Roche Diagnostics Automation Solutions, and Boston Scientific. Its strategic differentiation is maintained through a specialized focus on women's health, encompassing diagnostics, medical imaging, and surgical health, which provides a unique market positioning compared to competitors with broader or more upstream offerings.

What key technological partnerships is Hologic leveraging to advance its products?

Hologic is leveraging key technological partnerships, most notably with Google Cloud, to integrate machine learning and artificial intelligence into its next-generation digital diagnostic capabilities, such as the Genius Digital Diagnostics System. This collaboration aims to enhance laboratory performance and patient care.

How do Hologic's product offerings, such as the Genius Digital Diagnostics System and Envision Mammography Platform, indicate its innovation strategy?

Hologic's product offerings like the Genius Digital Diagnostics System, which combines AI with volumetric imaging, and the Envision Mammography Platform, featuring fast 3D scan times and Hologic AI, indicate a strong innovation strategy focused on integrating artificial intelligence and advanced imaging technologies. This aims to improve accuracy and efficiency in detecting pre-cancerous lesions, cervical cancer, and breast cancer.

What is the strategic objective behind Hologic's Global Access Initiative?

The strategic objective behind Hologic's Global Access Initiative, in partnership with CHAI and MedAccess, is to provide accessible and affordable diagnostic testing for HIV/AIDS, hepatitis, and cervical cancer in low- and middle-income countries. This initiative aims to expand global health equity by reducing the cost of testing using the Panther® system.

How does Hologic ensure the security of its healthcare solutions, given its hiring patterns?

Hologic ensures the security of its healthcare solutions by embedding a 'Secure by Design' principle, evidenced by its active recruitment for Product Security Engineer roles in multiple locations. This indicates a proactive approach to integrate security from the initial design phase of its medical devices and software.

What specialized imaging alternatives does Hologic face in the breast health market?

In the breast health market, Hologic faces specialized imaging alternatives such as AB-CT's nu:view system, which offers true 3D spiral breast CT without compression, and Siemens Healthineers' Mammomat B.brilliant platform, featuring FDA-cleared contrast-enhanced mammography (CEM) biopsy. These alternatives provide different imaging modalities with distinct advantages in image quality, patient comfort, and diagnostic capabilities.

What is Hologic's approach to talent development, particularly for leadership roles?

Hologic emphasizes developing talent from within, with 40% of its Global Leadership Team having grown into their roles through internal development and experience. This approach highlights a commitment to cultivating leadership through internal pathways and fostering career growth within the company.

How does Hologic's pricing strategy for its Panther® System reflect its commitment to global health?

Hologic's pricing strategy for its Panther® System demonstrates a strong commitment to global health through a significant agreement with MedAccess, Unitaid, and CHAI in 2018. This agreement substantially reduced the cost of diagnostic testing for HIV/AIDS, hepatitis, and cervical cancer for over 180 million individuals in low- and middle-income countries, subject to certain public-sector volume requirements.

Powered by ForesightIQ · Competitive intelligence from digital exhaust